in past times several years, the united kingdom has witnessed a revolution in clinical fat‑loss remedies — with the introduction of semaglutide (Wegovy®) towards the rising reputation of tirzepatide (Mounjaro®). Now, A different title is drawing attention in both equally clinical and community we